# Solid Biosciences Inc.: Form D filings

Solid Biosciences Inc., a pharmaceuticals company in Charlestown, MA, filed 3 Form D notices with the SEC between 2019 and 2022. The latest, on December 9, 2022, reports $9.2 million sold of a $9.2 million offering to 13 investors.

Find out what Solid Biosciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Solid%20Biosciences%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Solid%20Biosciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsolid-biosciences-inc-1707502)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Solid%20Biosciences%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Solid%20Biosciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsolid-biosciences-inc-1707502)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 500 RUTHERFORD AVENUE, 3RD FLOOR, Charlestown, MA, 02129
- Phone: (617) 337-4680
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1707502

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 9, 2022 | New notice | $9,200,000 | $9,200,000 | $0 | 13 | Dec 2, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1707502/000170750222000003/0001707502-22-000003-index.htm) |
| Oct 26, 2020 | New notice | $39,999,996 | $39,999,996 | $0 | 1 | Oct 22, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1707502/000170750220000001/0001707502-20-000001-index.htm) |
| Jul 31, 2019 | New notice | $59,977,035 | $59,977,035 | $0 | 15 | Jul 30, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1707502/000170750219000002/0001707502-19-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Lynne Tyronne Sullivan | Director |  |
| Adam Tyronne Koppel | Director |  |
| Stephen DiPalma | Executive Officer |  |
| Martin Tyronne Freed | Director |  |
| Alexander (Bo) Cumbo | Executive Officer, Director |  |
| Paul Tyronne Herizch | Executive Officer |  |
| Clare Tyronne Kahn | Director |  |
| Georgia Tyronne Keresty | Director |  |
| Adam Tyronne Stone | Director |  |
| Rajeev Tyronne Shah | Director |  |
| Robert Tyronne Huffines | Director |  |
| Carl Morris | Executive Officer |  |
| Jessie Tyronne Hanrahan | Executive Officer |  |
| Sukumar Tyronne Nagendran | Director |  |
| Ilan Tyronne Ganot | Director |  |
| David Tyronne Howton | Executive Officer |  |
| Jennifer Marlowe | Executive Officer |  |
| Ian Tyronne Smith | Director |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of Dec 5, 2022](https://specstream.ai/data/form-d/week/2022-12-05) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Solid Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).